1984
DOI: 10.1016/0002-9343(84)90367-x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical applications of angiotensin-converting enzyme inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
11
0
1

Year Published

1986
1986
2004
2004

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 37 publications
(12 citation statements)
references
References 90 publications
0
11
0
1
Order By: Relevance
“…ACE inhibitors have been used in the treatment of hypertension and congestive heart failure since 1977 when captopril, the first orally active ACE inhibitor, was introduced [16]. Apart from arterial hypertension where ACE inhibitors are recommended as first-line therapy by current guidelines [17], they are also recommended in several conditions.…”
Section: Discussionmentioning
confidence: 99%
“…ACE inhibitors have been used in the treatment of hypertension and congestive heart failure since 1977 when captopril, the first orally active ACE inhibitor, was introduced [16]. Apart from arterial hypertension where ACE inhibitors are recommended as first-line therapy by current guidelines [17], they are also recommended in several conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Today it is well known that ACE-inhibitors, used as therapeutic tools in the treatment of hypertension and congestive heart failure, are associated with adverse reactions in which the pathophysiology seems to be of inflammatory origin (Wilkin et al 1980;Sesoko & Kaneko 1985;Semple & Herd 1986;Suares et al 1986;Lindgren 1988). Several newly synthesized ACE-inhibitors are undergoing clinical evaluation in order to find ACE-inhibitors with fewer side effects and better safety profiles (Ferguson et al 1984;Fyhrqvist 1986). The pro-inflammatory effect of the ACE-inhibitor is related to the dosage (Wilkin et al 1980;Lindgren & Anderson 1989), as well as to its duration (Reid 1984;Skidgel et al 1984).…”
Section: Discussionmentioning
confidence: 99%
“…One incentive in inhibitor research is the control of limited proteolysis, as this constitutes a valuable pharmacological tool. Proteinase inhibitors have been proved effective in human therapy [10][11][12][27][28][29]. A pathological increase in fibrinolysis, e.g.…”
Section: Introductionmentioning
confidence: 99%